Utilizing Longitudinal DCE-MRI and Tumor Microenvironment Data for Predicting Neoadjuvant Therapy Outcomes in Breast Cancer Through Deep Learning Techniques - Top-Institutions - MDSpire

Utilizing Longitudinal DCE-MRI and Tumor Microenvironment Data for Predicting Neoadjuvant Therapy Outcomes in Breast Cancer Through Deep Learning Techniques

  • By

  • Lan Yan

  • Xianming Huang

  • Lan Liu

  • Ao Wu

  • Yingyi Luo

  • Hao Li

  • Shaofeng Yi

  • Tenghua Yu

  • Qiao Zeng

  • April 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Computational Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Medical Oncology
    • Bioinformatics

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Imaging
    • Radiation Oncology
    • Translational Research

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Radiology
    • Oncology
    • Artificial Intelligence in Medicine

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Breast Cancer Research
    • Radiology
    • Computational Biology

Original Source(s)

Utilizing Longitudinal DCE-MRI and Tumor Microenvironment Data for Predicting Neoadjuvant Therapy Outcomes in Breast Cancer Through Deep Learning Techniques

  • by Lan Yan, Xianming Huang, Lan Liu, Ao Wu, Yingyi Luo, Hao Li, Shaofeng Yi, Tenghua Yu, Qiao Zeng

  • April 28, 2026

Related Content

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer